Therefore, increased Foxp3/CD8, PD-1/CD4, and PD-1/CD8 ratios and VASH-1 expression in the tumor tissues were considered to suppress anti-tumor immunity more markedly in NEC than in non-NEC components of MiNENs. The gene discussed is CD8A; the disease is neuroendocrine carcinoma.